ZnT5 and ZnT6 were overexpressed in tumor tissues from 75% (6/8) of the patients, while ZnT7 and ZnT9 were overexpressed in tumor tissues from 87.5% (7/8) of the patients. Here, SLC30A7 is linked to neoplasm.